Antibiotics: study observes a decline in short-chain fatty acids in stool

Antibiotics can alter the activity of the microbiota, not just its composition. An analysis in young healthy volunteers reports a decline in short-chain fatty acids in stool during treatment with three antibiotics, with particularly widespread reductions under vancomycin. These findings describe metabolic changes, not a demonstrated deterioration in participants’ health.

Diagram of the gut microbiota and short-chain fatty acids measured in stool during antibiotic treatment.
NutritionEditorial illustration, not study data.

Three antibiotics compared over ten days

The researchers conducted a secondary analysis of a randomized, open-label phase 1 clinical trial. Participants received oral vancomycin, omadacycline or moxifloxacin for ten days.

Stool samples were collected before treatment, during treatment and at follow-up visits. They were used to measure short-chain fatty acids and characterize the microbiota. The supplied abstract specifies neither the sample size nor the total follow-up duration.

More widespread reductions with vancomycin

All three antibiotics reduced short-chain fatty acid levels during treatment. With vancomycin, the researchers describe an overall decrease from baseline, consistent with widespread suppression of microbial fermentation.

Vancomycin also altered the balance between straight-chain and branched-chain fatty acids, reducing their ratio. The authors interpret this finding as proportionally greater inhibition of fiber fermentation than of amino acid fermentation. However, the abstract does not quantify the magnitude of these changes.

An early sign of recovery in the capacity to produce butyrate was detected using a molecular measurement, qPCR, after omadacycline and moxifloxacin, but not after vancomycin. This measurement alone does not demonstrate a complete return to baseline.

Microbial markers, not a health assessment

The value of this analysis lies in tracking the products of microbial activity over the course of treatment. It suggests that the antibiotics studied do not all have the same effect on intestinal fermentation or on early signs of recovery.

The key limitation remains: the findings presented concern stool and microbial markers. They do not establish symptoms, lasting harm or changes in immunity. Observations in young healthy volunteers are also insufficient to predict effects in people being treated for an infection.

Limitations to keep in mind

Only the PubMed abstract was consulted, not the full text. The sample size, effect sizes, statistical uncertainties and follow-up duration are not specified in the excerpt. Funding and conflicts of interest could not be verified.

What we can take away

This study documents metabolic disturbances that differ by antibiotic. It does not support choosing a treatment on this criterion alone or recommending a supplement to aid recovery.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.